美国Pathway Genomics
Pathway Genomics拥有并经营一所现场基因检测实验室，该实验室已通过美国病理学家学会(CAP)的认证，该认证符合美国卫生及人民服务部的1988年临床实验室改进法案修正案(CLIA)，并持有加州颁发的许可证。该公司仅采用一份唾液样本，整合了量身定制的、经过科学验证的技术来生成个性化的报告，该报告可回答多种医学问题，包括个体是否携带某种隐性基因、食物代谢与运动反应、处方药物反应以及患某些疾病的倾向，如心脏病、2型糖尿病和癌症。


Pathway Genomics owns and operates an on-site genetic testing laboratory that is accredited by the College of American Pathologists (CAP), accredited in accordance with the U.S. Health and Human Services’ Clinical Laboratory Improvement Amendments (CLIA) of 1988, and licensed by the state of California. Using only a saliva sample, the company incorporates customized and scientifically validated technologies to generate personalized reports, which address a variety of medical issues, including an individual’s carrier status for recessive genetic conditions, food metabolism and exercise response, prescription drug response, and propensity to develop certain diseases such as heart disease, type 2 diabetes and cancer.